Skip to main content

Table 1 Discovery and validation results from affected/unaffected comparison selected proteins

From: Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches

Protein

Discovery p value (FC)

Synthesised peptides

Validation p value (FC)

P05090|APOD

0.03 (2.55)

VLNQELR

0.22 (1.51)

NILTSNNIDVK

D

P43897|TSFM

0.04 (0.35)

GFLNSSELSGLPAGPDR

D

TNLEDVGR

0.15 (4.37)

LGQHVVGMAPLSVGSLDDEPGGEAETK

D

P62266|RPS23

0.01 (0.36)

AHLGTALK

0.10 (2.39)

VANVSLLALYK

D

P30740|SERPINB1

0.04 (0.38)

TYNFLPEFLVSTQK

0.46 (0.66)

TYGADLASVDFQHASEDAR

D

LGVQDLFNSSK

D

P09936|UCHL1

0.00 (2.52)

LGVAGQWR

D

LGFEDGSVLK

D

NEAIQAAHDAVAQEGQC[+57]R

0.01 (2.62)

P02743|APCS

0.02 (2.58)

VGEYSLYIGR

D

IVLGQEQDSYGGK

0.05 (5.54)

Q53GQ0|HSD17B12

0.00 (0.37)

TIAVDFASEDIYDK

0.41 (0.58)

GVFVQSVLPYFVATK

D

Q08752|PPID

0.04 (2.50)

IVLELFADIVPK

N/D

VFFDVDIGGER

D

ILLITEDLK

0.02 (1.69)

Q8NHQ9|DDX55

0.04 (3.33)

DVAAEAVTGSGK

D

SLDVLVLDEADR

0.03 (4.40)

TGLFSATQTQEVENLVR

D

Q15154|PCM1

0.04 (2.98)

INFSDLDQR

N/D

LPEMEPLVPR

N/D

ALYALQDIVSR

N/D

P14854|COX6B1

0.02 (5.26)

NC[+57]WQNYLDFHR

0.02 (3.73)

GGDISVC[+57]EWYQR

D

Q99504|EYA3

0.02 (4.18)

LSSGDPSTSPSLSQTTPSKDTDDQSR

0.49 (0.73)

VLLYGLGEIFPIENIYSATK

D

Q9Y262|EIF3L

0.03 (0.38)

VYEIQDIYENSWTK

0.28 (0.64)

VFSDEVQQQAQLSTIR

D

LAGFLDLTEQEFR

D

  1. This table shows the selected proteins from affected/unaffected comparison, their synthesised peptides and p value and FC from discovery and validation phases. Peptide sequence with bold font indicates the peptides that were used for quantification. The remaining peptides were used as quality controls. Bold font in validation p value (FC) column indicates the significant p values in the validation phase
  2. D detected, N/D not detected